Literature DB >> 14500876

The specificity of cross-reactivity: promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness.

Leo C James1, Dan S Tawfik.   

Abstract

Proteins are renowned for their specificity of function. There is, however, accumulating evidence that many proteins, from enzymes to antibodies, are functionally promiscuous. Promiscuity is of considerable physiological importance. In the immune system, cross-reactive or multispecific antibodies are implicated in autoimmune and allergy conditions. In most cases, however, the mechanism behind promiscuity and the relationship between specific and promiscuous activities are unknown. Are the two contradictory? Or can a protein exhibit several unrelated activities each of which is highly specific? To address these questions, we studied a multispecific IgE antibody (SPE7) elicited against a 2,4-dinitrophenyl hapten (DNP). SPE7 is able to distinguish between closely related derivatives such as NP (nitrophenol) and DNP, yet it can also bind a number of unrelated ligands. We find that, like DNP, the cross-reactants are themselves bound specifically-close derivatives of these cross-reactants show very low or no binding to SPE7. It has been suggested that cross-reactivity is simply due to "hydrophobic stickiness", nonspecific interactions between hydrophobic ligands and binding sites. However, partitioning experiments reveal that affinity for SPE7 is unrelated to ligand hydrophobicity. These data, combined with crystal structures of SPE7 in complex with four different ligands, demonstrate that each cross-reactant is bound specifically, forming different hydrogen bonds dependant upon its particular chemistry and the availability of complementary antibody residues. SPE7 is highly homologous to the germline antinitrophenol (NP) antibody B1-8. By comparing the sequences and binding patterns of SPE7 and B1-8, we address the relationship between affinity maturation, specificity, and cross-reactivity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500876      PMCID: PMC2366915          DOI: 10.1110/ps.03172703

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  33 in total

1.  Convergent solutions to binding at a protein-protein interface.

Authors:  W L DeLano; M H Ultsch; A M de Vos; J A Wells
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

Review 2.  Catalytic promiscuity and the evolution of new enzymatic activities.

Authors:  P J O'Brien; D Herschlag
Journal:  Chem Biol       Date:  1999-04

Review 3.  Moonlighting proteins.

Authors:  C J Jeffery
Journal:  Trends Biochem Sci       Date:  1999-01       Impact factor: 13.807

Review 4.  Mycoplasma-pneumoniae-induced thrombotic thrombocytopenic purpura.

Authors:  E Bar Meir; H Amital; Y Levy; A Kneller; Y Bar-Dayan; Y Shoenfeld
Journal:  Acta Haematol       Date:  2000       Impact factor: 2.195

5.  Conformational changes affect binding and catalysis by ester-hydrolysing antibodies.

Authors:  A B Lindner; Z Eshhar; D S Tawfik
Journal:  J Mol Biol       Date:  1999-01-08       Impact factor: 5.469

6.  Immune versus natural selection: antibody aldolases with enzymic rates but broader scope.

Authors:  C F Barbas; A Heine; G Zhong; T Hoffmann; S Gramatikova; R Björnestedt; B List; J Anderson; E A Stura; I A Wilson; R A Lerner
Journal:  Science       Date:  1997-12-19       Impact factor: 47.728

7.  The catalytic reaction and inhibition mechanism of Drosophila alcohol dehydrogenase: observation of an enzyme-bound NAD-ketone adduct at 1.4 A resolution by X-ray crystallography.

Authors:  J Benach; S Atrian; R Gonzàlez-Duarte; R Ladenstein
Journal:  J Mol Biol       Date:  1999-06-04       Impact factor: 5.469

8.  Antibody fragment Fv4155 bound to two closely related steroid hormones: the structural basis of fine specificity.

Authors:  C H Trinh; S D Hemmington; M E Verhoeyen; S E Phillips
Journal:  Structure       Date:  1997-07-15       Impact factor: 5.006

9.  Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin.

Authors:  D Fairweather; C M Lawson; A J Chapman; C M Brown; T W Booth; J M Papadimitriou; G R Shellam
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

Review 10.  Molecular mimicry and immune-mediated diseases.

Authors:  M B Oldstone
Journal:  FASEB J       Date:  1998-10       Impact factor: 5.191

View more
  48 in total

Review 1.  Polyreactive antibodies in adaptive immune responses to viruses.

Authors:  Hugo Mouquet; Michel C Nussenzweig
Journal:  Cell Mol Life Sci       Date:  2011-11-02       Impact factor: 9.261

2.  Immunopotentiating properties of a multispecific α-anti-idiotype antibody.

Authors:  Tays Hernández; Cristina Mateo de Acosta; Rolando Pérez
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

3.  Structure and kinetics of a transient antibody binding intermediate reveal a kinetic discrimination mechanism in antigen recognition.

Authors:  Leo C James; Dan S Tawfik
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

4.  Cross-reactivity and conformational multiplicity of an anti-polycyclic aromatic hydrocarbon mAb.

Authors:  Nenad M Grubor; John Hayes; Gerald J Small; Ryszard Jankowiak
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-11       Impact factor: 11.205

5.  Specificity in molecular design: a physical framework for probing the determinants of binding specificity and promiscuity in a biological environment.

Authors:  Mala L Radhakrishnan; Bruce Tidor
Journal:  J Phys Chem B       Date:  2007-11-03       Impact factor: 2.991

Review 6.  Protein promiscuity and its implications for biotechnology.

Authors:  Irene Nobeli; Angelo D Favia; Janet M Thornton
Journal:  Nat Biotechnol       Date:  2009-02       Impact factor: 54.908

7.  Contribution of asparagine residues to the stabilization of a proteinaceous antigen-antibody complex, HyHEL-10-hen egg white lysozyme.

Authors:  Akiko Yokota; Kouhei Tsumoto; Mitsunori Shiroishi; Takeshi Nakanishi; Hidemasa Kondo; Izumi Kumagai
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

8.  Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids.

Authors:  Norman R Watts; Giovanni Cardone; Joe G Vethanayagam; Naiqian Cheng; Catharina Hultgren; Stephen J Stahl; Alasdair C Steven; Matti Sällberg; Paul T Wingfield
Journal:  J Mol Biol       Date:  2008-04-09       Impact factor: 5.469

9.  Inhibition of weak-affinity epitope-IgE interactions prevents mast cell degranulation.

Authors:  Michael W Handlogten; Tanyel Kiziltepe; Ana P Serezani; Mark H Kaplan; Basar Bilgicer
Journal:  Nat Chem Biol       Date:  2013-10-06       Impact factor: 15.040

10.  Defining the complementarities between antibodies and haptens to refine our understanding and aid the prediction of a successful binding interaction.

Authors:  Mohammed M Al Qaraghuli; Soumya Palliyil; Gillian Broadbent; David C Cullen; Keith A Charlton; Andrew J Porter
Journal:  BMC Biotechnol       Date:  2015-10-24       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.